logo

For the Inventor, By the Inventor

Framingham, MA, United States of America

Berg LLC


USPTO Granted Patents = 37

% Expired Patents = 13.5



Trademarks = 7

Forward Citations = 126

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Niven Rajin Narain (34 out of 51 patents)

silverMedal Rangaprasad Sarangarajan (24 out of 30 patents)

bronzeMedal John Patrick McCook (14 out of 25 patents)

4.  Vivek Kannoth Vishnudas (14 out of 14 patents)

5.  Joaquin J Jimenez (6 out of 14 patents)

6.  Enxuan Jing (5 out of 5 patents)

7.  Stephane Gesta (4 out of 4 patents)

8.  Nikunj Narendra Tanna (4 out of 4 patents)

9.  Shen Luan (3 out of 3 patents)

10.  Viatcheslav R Akmaev (3 out of 13 patents)

11.  Indushekhar Persaud (3 out of 10 patents)

12.  Michael Andrew Kiebish (3 out of 6 patents)

13.  Thomas Mitchell Gray (2 out of 4 patents)

14.  Dinesh U Chimmanamada (1 out of 46 patents)

15.  Paula Patricia Narain (1 out of 1 patent)


Core Competencies:
Drug-Induced Toxicity
Biomarkers
Coenzyme Q10
Cancer Treatment
Apoptosis Induction
Parkinson's Disease
Inhalable Formulations
Metabolic Syndrome
Filamin A
Stress-Induced Disorders
Tumor Prevention
Healthcare Diagnosis

37 patents:

1. 11694765 - Interrogatory cell-based assays for identifying drug-induced toxicity markers (2023-07-04),
2. 11622948 - Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders (2023-04-11),
3. 11456054 - Interrogatory cell-based assays and uses thereof (2022-09-27),
4. 11452699 - Method of treating or preventing tumors of the central nervous system (2022-09-27),
5. 11419830 - Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2022-08-23),
6. 11400058 - Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof (2022-08-02),
7. 11305016 - Vitamin D3 and analogs thereof for treating alopecia (2022-04-19),
8. 11298313 - Methods of treatment of cancer by continuous infusion of coenzyme Q10 (2022-04-12),
9. 11224641 - Enolase 1 (ENO1) compositions and uses thereof (2022-01-18),
10. 11209422 - Methods and kits for detection of coenzyme Q10 (2021-12-28),
11. 11091447 - UBE2K modulators and methods for their use (2021-08-17),
12. 11028446 - Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) (2021-06-08),
13. 11001891 - Methods for treating Parkinson's disease (2021-05-11),
14. 10973763 - Inhalable pharmaceutical compositions (2021-04-13),
15. 10933032 - Methods for the treatment of cancer using coenzyme Q10 combination therapies (2021-03-02),
Berg LLC is a biotechnology company based in Framingham, MA, specializing in the development of innovative solutions in the fields of healthcare and life sciences. The organization focuses on leveraging advanced technologies, including artificial intelligence and data analytics, to enhance drug discovery and personalized medicine. By integrating biological insights with computational methods, Berg aims to address complex health challenges and improve patient outcomes through targeted therapeutic strategies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

37 Patents

#7 in Framingham, MA

#537 in Massachusetts

#9,241 in US

#18,238 in the World

Framingham, MA (US)
Framingham, MA, United States of America

Berg LLC

Forward Citations = 126

26 inventors:

goldMedal Niven Rajin Narain (34 out of 51 patents)

silverMedal Rangaprasad Sarangarajan (24 out of 30 patents)

bronzeMedal John Patrick McCook (14 out of 25 patents)

4.  Vivek Kannoth Vishnudas (14 out of 14 patents)

5.  Joaquin J Jimenez (6 out of 14 patents)

Please report any incorrect information to [email protected]
Loading…